Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-β1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair

被引:81
作者
Fan, Hongbin
Hu, Yunyu [1 ]
Qin, Ling
Li, Xusheng
Wu, Hong
Lv, Rong
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China
[2] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China
[3] Fourth Mil Med Univ, Dept Chem, Xian 710032, Peoples R China
关键词
mesenchymal stem cell; scaffold; transforming growth factor; microsphere; tissue engineering;
D O I
10.1002/jbm.a.30647
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of the study was to produce a novel porous gelatin-chondroitin-hyaluronate scaffold in combination with a controlled release of transforming growth 0 factor beta 1 (TGF-beta 1), which induced the differentiation of mesenchymal stem cells (MSCs) in vivo for enhancing cartilage repair. Gelatin microspheres loaded with TGF-beta 1 (MSTGF beta 1) showed a fast release at the initial phase (37.4%,), and the ultimate accumulated release,vas 83.1%, by day 18. The autologous NMSCs seeded on MS-TGF beta 1/scaffold were implanted to repair full-thickness cartilage defects in rabbits as in vivo differentiation repair group, while MSCs differentiated in vitro were seeded on scaffold without MS-TGF beta 1 to repair the contra lateral cartilage defects (n = 30). Fifteen additional rabbits without treatment for defects were used as control. Histology observation showed that the in vivo differentiation repair group had better chondrocyte morphology, integration, continuous subchondral bone, and much thicker newly formed cartilage layer when compared to in vilro differentiation repair group 12 and 24 weeks, postoperatively. There was a significant difference in histological grading score between these two experimental groups, and both showed much better repair than that of the control. The present study implied that the novel scaffold with MS-TGF beta 1 might serve as a new way to induce the differentiation of MSCs in vivo to enhance the cartilage repair. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:785 / 794
页数:10
相关论文
共 46 条
[1]   Large osteochondral defects of the femoral condyle: press-fit transplantation of the posterior femoral condyle (MEGA-OATS) [J].
Agneskirchner, JD ;
Brucker, P ;
Burkart, A ;
Imhoff, AB .
KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2002, 10 (03) :160-168
[2]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[3]  
Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
[4]   TREATMENT OF DEEP CARTILAGE DEFECTS IN THE KNEE WITH AUTOLOGOUS CHONDROCYTE TRANSPLANTATION [J].
BRITTBERG, M ;
LINDAHL, A ;
NILSSON, A ;
OHLSSON, C ;
ISAKSSON, O ;
PETERSON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :889-895
[5]  
Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO
[6]  
2-J
[7]   Scaffold-based articular cartilage repair [J].
Capito, RM ;
Spector, M .
IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 2003, 22 (05) :42-50
[8]   Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering [J].
Chang, CH ;
Liu, HC ;
Lin, CC ;
Chou, CH ;
Lin, FH .
BIOMATERIALS, 2003, 24 (26) :4853-4858
[9]  
CUI YM, 2003, J CHIN REHABIL, V7, P2397
[10]  
FAN HB, 2005, ORTHOP J CHIN, V13, P208